Why One Number Isn’t Enough for Patients - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

  • By

  • Kerri Miller

  • March 5, 2026

  • 2 min

Share

Objective:

To highlight the importance of providing comparative risk numbers to patients for better understanding and decision-making.

Approach:
    Key Findings:
    • Patients find risk numbers more meaningful when they are presented alongside a comparative figure.
    • Risk perceptions change based on whether the comparison is higher or lower than average.
    • Silence about alternatives can inflate perceptions of treatment effectiveness.
    Interpretation:

    Providing a second number alongside a risk statistic helps patients better understand their health risks and treatment options.

    Limitations:
    • The article does not address potential barriers to implementing this communication strategy in clinical practice.
    • It does not explore the impact of individual patient differences on the interpretation of comparative numbers.
    Conclusion:

    Using comparative statistics can enhance patient understanding and improve decision-making in healthcare.

    Sources:

Original Source(s)

Why One Number Isn’t Enough for Patients

  • by Kerri Miller

  • March 5, 2026

Related Content

36 genes may reshape OCD, tic genetics

Whole-exome sequencing identifies large-effect risk genes across obsessive-compulsive and chronic tic disorders, with most supported by both conditions.

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.

Social vulnerability may contribute to disparities in ovarian cancer survival

Neighborhood vulnerability was associated with poorer survival among women with epithelial ovarian cancer, with a stronger association among Black women.